Please assess the completion status of the following clinical trial:

Trial Title: Respiratory and Autonomic Plasticity Following Intermittent Hypoxia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Characteristics of OSA subject population:~* Body mass index \< 30 kg/m2.~* 20 to 40 years old.~* Newly diagnosed never-treated mild to moderate sleep apnea (i.e. 50 \> apnea/hypopnea index \>10 events per hour - average nocturnal oxygen saturation \> 90%).~* Not pregnant.~* Free of any other known medical conditions.~* Not taking any medication.~* Non-smokers with normal lung function.~* Minimal alcohol consumption (i.e. no more than the equivalent of a glass of wine/day).~Characteristics of control group population:~* Body mass index \< 30 kg/m2.~* 20 to 40 years old.~* Apnea/hypopnea index \< 5 events per hour.~* Not pregnant.~* Free of any known medical conditions.~* Not taking any medication.~* Non-smokers with normal lung function.~* Minimal alcohol consumption (i.e. no more than the equivalent of a glass of wine/day).~Exclusion Criteria:~* Anything not in inclusion criteria.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Arm 1 (Type: NO_INTERVENTION): We plan to study 10 males and 10 females with moderate obstructive sleep apnea (OSA), and 10 healthy males and 10 healthy females. The males and the females will be matched based on age, race, sex and body mass index. The OSA and control participants will be exposed to intermittent hypoxia and sham intermittent hypoxia during wakefulness and sleep.
- ANTIOXIDANT COCKTAIL (Type: EXPERIMENTAL): We plan to study 10 male participants with moderate obstructive sleep apnea (OSA) and 10 male control participants matched for age, race and body mass index. The OSA and control participants will be exposed to intermittent hypoxia during wakefulness and sleep following administration of an antioxidant or a placebo cocktail that will be presented in a randomized fashion.

Based on this trial design, predict the completion outcome and termination type (if applicable).